Showing results (941-950 of 9,109) with videos related to
Sort By:
Pageof 911
Cancer Medicine|January 9, 2021
Cumulative incidence of venous thromboembolism in patients with advanced cancer in prospective observational studyHirotsugu Kenmotsu, Akifumi Notsu, Keita Mori, et al.Cancer Medicine|January 10, 2021
Regional and temporal variation in receipt of long-term opioid therapy among older breast, colorectal, lung, and prostate cancer survivors in the United StatesDerrick C Gibson, Mukaila A Raji, Jacques G Baillargeon, et al.Cancer Medicine|June 26, 2021
Next-generation sequencing of tissue and circulating tumor DNA: Resistance mechanisms to EGFR targeted therapy in a cohort of patients with advanced non-small cell lung cancerYujun Zhang, Liwen Xiong, Fangfang Xie, et al.Cancer Medicine|June 19, 2021
Methylation of three genes encoded by X chromosome in blood leukocytes and colorectal cancer riskTian Tian, Haoran Bi, Ding Zhang, et al.Cancer Medicine|June 19, 2021
Weight and weight control behaviors during long-term endometrial cancer survivorship: Results of the Laparoscopic Approach to Cancer of the Endometrium long-term follow-up studyMonika Janda, Peta Forder, Val Gebski, et al.Cancer Medicine|June 19, 2021
Ppp6c deficiency accelerates K-rasG12D -induced tongue carcinogenesisKazuhiro Kishimoto, Kosuke Kanazawa, Miyuki Nomura, et al.Cancer Medicine|June 8, 2021
Characterizing online crowdfunding campaigns for patients with kidney cancerHannah S Thomas, Austin W Lee, Behnam Nabavizadeh, et al.Cancer Medicine|June 8, 2021
Randomized study of remote telehealth genetic services versus usual care in oncology practices without genetic counselorsCara N Cacioppo, Brian L Egleston, Dominique Fetzer, et al.Cancer Medicine|June 14, 2021
Association of immune-related pneumonitis with clinical benefit of anti-programmed cell death-1 monotherapy in advanced non-small cell lung cancerKana Ono, Hirotaka Ono, Yukihiro Toi, et al.Cancer Medicine|June 14, 2021
Integrative analysis of TP73 profile prognostic significance in WHO grade II/III gliomaYanming Chen, Ye Wang, Qiheng He, et al.Pageof 911